We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
XTRA:4LN2
logo

Capricor Therapeutics (4LN2)

XTRA • 4LN2 • US14070B3096

7.37Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 4, 2026, ORTEX estimated 20.6% of free float sold short, cost to borrow 2.54%. Sign up for live short interest data.

Market Cap

489m USD | # 6049 in DE

Volume

902 shares | 21.38k USD

Shares Outstanding

58.14m

Free Float Shares

85.38% | 49.64m

Nasdaq:CAPR|
DB:4LN2

News

4LN2 key data

Capricor Therapeutics (XTRA: 4LN2) has a market capitalization of $488.98M. Last close €7.37 (as of 2026-11-20); 52-week range €5.19 to €10.06. ORTEX data as of 2026-11-04: short interest was 20.59% of free float and the average cost to borrow was 2.54%. Sign up for live short interest data.

  • 4LN2 news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.